& Delivery, Collaboration, Partnership and Integrity. We want to be the ClinicalResearch Organisation that delivers excellence... in English and Turkish Supporting the Study Start up Associate with tasks including; tracking, filling, collating...
& Delivery, Collaboration, Partnership and Integrity. We want to be the ClinicalResearch Organisation that delivers excellence...Study Start Up Associate II At ICON, it’s our people that set us apart. Our diverse teams enable...
& Delivery, Collaboration, Partnership and Integrity. We want to be the ClinicalResearch Organisation that delivers excellence... in English and Turkish Supporting the Study Start up Associate with tasks including; tracking, filling, collating...
Senior ClinicalResearchAssociate IQVIA is the Human Data Science Company oriented to drive human health outcomes... of clinicalresearch regulatory requirements Very good computer skills including MS Office Excellent command of Turkish...
ClinicalResearchAssociate IQVIA Turkey is looking for talented and motivated team member to join our Sponsor... analytics, technology solutions and clinicalresearch services to the life sciences industry. We believe in pushing the...
) to receive an alert: × Select how often (in days) to receive an alert: ClinicalResearchAssociate (CRA) - Talent Pipeline... expanding company? Join Novo Nordisk Turkey as ClinicalResearchAssociate (CRA) / Senior CRA and get a life-changing career...
ClinicalResearchAssociate IQVIA Turkey is looking for talented and motivated team member to join our Sponsor... IQVIA is a leading global provider of advanced analytics, technology solutions and clinicalresearch services to the life...
. As a ClinicalResearchAssociate at ICON, you’ll work within a large-scale, fast-paced environment alongside a close-knit team... and Integrity. We want to be the ClinicalResearch Organisation that delivers excellence to our clients and to patients at every...
. The position As a ClinicalResearchAssociate (CRA), you will conduct site selection, initiation, monitoring, and closure... next step in your professional development in a globally expanding company? Join Novo Nordisk Turkey as ClinicalResearch...
Economic and Outcomes Research (HEOR) team to establish scientific and clinical credibility for clinical outcomes focused... affairs activities. An understanding of Good Clinical Practices, ICH guidelines, PhRMA code, FDACFR, ISO, clinicalresearch...
India end their 13-year wait for a world title by fighting back for a thrilling seven-run win over South Africa in the T20 World Cup final. Continue Reading »
The shares of Emcure Pharma IPO is trading at a premium of ₹255 in the grey market premium (GMP) on Saturday, June 29, just days before the issue opens for subscription, according to investorgain.com. Continue Reading »
Dividend Stocks: Several companies including Mahindra & Mahindra, Piramal Enterprises, Tata Power, among others are trading ex-dividend in the coming week. Continue Reading »
According to Ravi Singh, SVP- Retail Research, Religare Broking Ltd, Infrastructure investment is set to focus on sustainability, aiming to modernize transport networks and improve environmental outcomes. Continue Reading »
Nike, the world’s largest sportswear company has been seeing a revenue decline to the mid-single digits in the company’s current fiscal year, while investors had expected an increase. Continue Reading »
Mid and small-cap stocks in India have shown strong performance, but high valuations make them volatile. Experts advise a cautious approach and suggest focusing on quality stocks for potential alpha returns. Selectivity and bottom-up investment approach are recommended for long-term wealth creation. Continue Reading »
The final date for Vraj Iron and Steel IPO bidding has passed, with allotment expected on July 1, 2024. The issue price range was ₹195-207, with shares trading at a 75% premium in the grey market. Continue Reading »
FPI inflows into Indian equities were modest in the first half of 2024 but surged in June with ₹26,565 crore. Experts predict a strong second half due to economic growth prospects, potential rate cuts, and positive sentiment. Continue Reading »